DiaMedica Therapeutics Inc. (NASDAQ:DMAC)
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$37.5M
- Net margin
- —
Little or no net debt.
- Total debt
- $185K
- Cash
- $5.1M
- Debt / equity
- 0.00
Comfortably covers what is due within a year.
- Current assets
- $44.3M
- Current liabilities
- $6.6M
- Current ratio
- 6.72
Consumes cash and must keep raising it.
- Operating cash flow
- -$31.6M
- Free cash flow
- -$31.6M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 53.9M
- Share growth (1y)
- 25.5%
- Cash runway
- 2 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
DMAC Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 2.35 M | 2.50 M | 2.51 M | 2.60 M | 2.19 M | 2.49 M |
| R&D Expense | 8.15 M | 7.99 M | 6.70 M | 6.44 M | 5.82 M | 5.66 M |
| Operating Expenses | 10.13 M | 10.48 M | 9.21 M | 9.03 M | 8.01 M | 8.14 M |
| Operating Income | -10.13 M | -10.48 M | -9.21 M | -9.03 M | -8.01 M | -8.14 M |
| Pretax Income | -10.13 M | -10.04 M | -8.73 M | -8.61 M | -7.69 M | -7.70 M |
| Tax Provision | 7.00 K | -7.00 K | 10.00 K | 6.00 K | 6.00 K | 6.00 K |
| Net Income | -10.14 M | -10.04 M | -8.74 M | -8.62 M | -7.70 M | -7.71 M |
| EPS (Basic) | -0.19 | -0.19 | -0.17 | -0.17 | -0.18 | -0.18 |
| EPS (Diluted) | -0.19 | -0.19 | -0.17 | -0.17 | -0.18 | -0.18 |
| Shares Outstanding | 53.89 M | 53.79 M | 46.98 M | 49.63 M | 42.96 M | 42.84 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.